Similar, albeit less pronounced results were obtained with BT549 breast cancer cells (Fig. 2D), but under these conditions, neither HGF, rapamycin, nor HGF + rapamycin had significant effects on BT549 cell proliferation. This evidence concerns the gene HGF and breast carcinoma.